http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11537203

Outgoing Links

Predicate Object
contentType Journal Article
issn 1471-2407
issueIdentifier 1
pageRange 278-
publicationName BMC Cancer
startingPage 278
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b6e0bd822097decd1a92f110197088f2
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ddc7d132b30e91a12f7bf851286e883e
bibliographicCitation Bi N, Liu L, Liang J, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang J, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Zhang T, Yin W, Li J, He J, Wang L. Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial. BMC Cancer. 2020 Apr 06;20(1):278. PMID: 32252680; PMCID: PMC7137304.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d93a7d0d6b49a51764bfb692afd3071
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_696c68bf03431bca9b075343c03896f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af77652f4478f0991baf99c88b907e89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d69e410ac881f30617bd152f445c374
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35323b005ce30c200a293b1fa60c4bcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8af397991d35e2f207c6b863feb531ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c664bcb494545354e72e973d955061c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99ce3a52710d90a38e031f61b516c557
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e68780497bfc3ecf8d1e2936c555560a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab64edc19462134897e6b38bdf6a40c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bf8476d5b92f32235bdfc6974023f04
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1e35a1e6733f67778dff18aca1ea8cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99afb0a89f8cd12ed96426612f332da9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_302fe4d4ba0733ccc93b2882a513fe37
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f40eb70ce312ebfd635870b3e12c55e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89f3098acafc7bcde459c70f5965d5da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75b1c469d06744eb3d1fbc362bcf3ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51383f678ae36e9422bac4259782506d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7af4317a2b1e26b7667b916a23a666e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63549e1134a61227fd12478498774c1f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d61e7489c0730b02c1f847f777c0d9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2febd6dbabe0218f487bcba9f45e97af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7da2e47751a15f361739b9bbaef4dd9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aed04dfb3d29849a613903fb4184ad63
date 2020-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s12885-020-06780-x
https://pubmed.ncbi.nlm.nih.gov/PMC7137304
https://pubmed.ncbi.nlm.nih.gov/32252680
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial
discusses http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0004505
http://id.nlm.nih.gov/mesh/M0007930
http://id.nlm.nih.gov/mesh/M0024707
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10051
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756

Total number of triples: 57.